Department of Pediatrics Archive — Page 37 of 55
-
September 20, 2018
Patient’s indomitable spirit makes Lily’s Garden grow
Lily Hensiek, diagnosed with pre B cell acute lymphoblastic leukemia 10 years ago at age 7, has helped raise $1 million, through community fundraisers and individual donors, to create two funds to support pediatric cancer research and training at Monroe Carell Jr. Children’s Hospital at Vanderbilt. The funds are the Lily’s Garden Endowed Lecture in Childhood Cancer and the Lily’s Garden Research Fund. -
September 13, 2018
Healthy antibodies reverse diabetes
Vanderbilt researchers have discovered that IgM-type antibodies appear to play a protective role to prevent the development of type 1 diabetes — and that purified IgM antibodies can reverse the disease. -
September 13, 2018
People power Department of Pediatrics’ success: Webber
Steven Webber, MBChB, MRCP, chair of the Department of Pediatrics, delivered the annual State of the Department address Sept. 4, celebrating the people that form the department while reviewing major achievements in the past year and discussing the opportunities and challenges that lie ahead. -
August 30, 2018
Children’s Hospital launches pediatric food allergy clinic
Monroe Carell Jr. Children’s Hospital at Vanderbilt has launched a new pediatric food allergy clinic. -
August 16, 2018
Risk factors for faulty rhythms
Risk factors for arrhythmias after heart surgery in infants include medications, infant age and higher surgical complexity, but not two genetic variants examined by Vanderbilt researchers. -
August 9, 2018
Kropski, Shoemaker honored by Doris Duke Foundation
Two early-career physician-scientists at Vanderbilt University Medical Center are among 18 recipients of 2018 Clinical Scientist Development Awards announced July 31 by the Doris Duke Charitable Foundation. -
July 26, 2018
VUMC’s membership in NIH NeuroNEXT network renewed
The National Institutes of Health (NIH) has renewed Vanderbilt University Medical Center’s membership in NeuroNEXT, a research network that helps streamline Phase 2 clinical trials for brain disorders.